Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Supranutritional selenium induces alterations in molecular targets related to energy metabolism in skeletal muscle and visceral adipose tissue of pigs.

Pinto A, Juniper DT, Sanil M, Morgan L, Clark L, Sies H, Rayman MP, Steinbrenner H.

J Inorg Biochem. 2012 Sep;114:47-54. doi: 10.1016/j.jinorgbio.2012.04.011. Epub 2012 Apr 30.

PMID:
22694857
2.

Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial.

Alizadeh M, Safaeiyan A, Ostadrahimi A, Estakhri R, Daneghian S, Ghaffari A, Gargari BP.

Ann Nutr Metab. 2012;60(2):157-68. doi: 10.1159/000335470. Epub 2012 Apr 18.

PMID:
22517293
3.

Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes.

Misu H, Ishikura K, Kurita S, Takeshita Y, Ota T, Saito Y, Takahashi K, Kaneko S, Takamura T.

PLoS One. 2012;7(4):e34952. doi: 10.1371/journal.pone.0034952. Epub 2012 Apr 4.

4.

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LH.

JAMA. 2011 Oct 12;306(14):1549-56. doi: 10.1001/jama.2011.1437.

5.

Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis.

Yang SJ, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM.

J Clin Endocrinol Metab. 2011 Aug;96(8):E1325-9. doi: 10.1210/jc.2011-0620. Epub 2011 Jun 15.

PMID:
21677040
6.

Effect of supplementation with high-selenium yeast on plasma lipids: a randomized trial.

Rayman MP, Stranges S, Griffin BA, Pastor-Barriuso R, Guallar E.

Ann Intern Med. 2011 May 17;154(10):656-65. doi: 10.7326/0003-4819-154-10-201105170-00005.

PMID:
21576533
7.

Associations of selenium status with cardiometabolic risk factors: an 8-year follow-up analysis of the Olivetti Heart study.

Stranges S, Galletti F, Farinaro E, D'Elia L, Russo O, Iacone R, Capasso C, Carginale V, De Luca V, Della Valle E, Cappuccio FP, Strazzullo P.

Atherosclerosis. 2011 Jul;217(1):274-8. doi: 10.1016/j.atherosclerosis.2011.03.027. Epub 2011 Mar 30.

PMID:
21497349
8.

The influence of selenium-enriched milk proteins and selenium yeast on plasma selenium levels and rectal selenoprotein gene expression in human subjects.

Hu Y, McIntosh GH, Le Leu RK, Upton JM, Woodman RJ, Young GP.

Br J Nutr. 2011 Aug;106(4):572-82. doi: 10.1017/S0007114511000420. Epub 2011 Mar 30.

PMID:
21450115
9.

High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism.

Steinbrenner H, Speckmann B, Pinto A, Sies H.

J Clin Biochem Nutr. 2011 Jan;48(1):40-5. doi: 10.3164/jcbn.11-002FR. Epub 2010 Dec 28.

10.

Both maximal expression of selenoproteins and selenoprotein deficiency can promote development of type 2 diabetes-like phenotype in mice.

Labunskyy VM, Lee BC, Handy DE, Loscalzo J, Hatfield DL, Gladyshev VN.

Antioxid Redox Signal. 2011 Jun 15;14(12):2327-36. doi: 10.1089/ars.2010.3526. Epub 2011 Mar 21.

11.

Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes.

Montonen J, Drogan D, Joost HG, Boeing H, Fritsche A, Schleicher E, Schulze MB, Pischon T.

Eur J Epidemiol. 2011 Jan;26(1):29-38. doi: 10.1007/s10654-010-9539-0. Epub 2010 Dec 28.

PMID:
21188480
12.

Selenium status and cardiometabolic health: state of the evidence.

Stranges S, Navas-Acien A, Rayman MP, Guallar E.

Nutr Metab Cardiovasc Dis. 2010 Dec;20(10):754-60. doi: 10.1016/j.numecd.2010.10.001. Epub 2010 Nov 20. Review.

PMID:
21094028
13.

Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans.

Schoenmakers E, Agostini M, Mitchell C, Schoenmakers N, Papp L, Rajanayagam O, Padidela R, Ceron-Gutierrez L, Doffinger R, Prevosto C, Luan J, Montano S, Lu J, Castanet M, Clemons N, Groeneveld M, Castets P, Karbaschi M, Aitken S, Dixon A, Williams J, Campi I, Blount M, Burton H, Muntoni F, O'Donovan D, Dean A, Warren A, Brierley C, Baguley D, Guicheney P, Fitzgerald R, Coles A, Gaston H, Todd P, Holmgren A, Khanna KK, Cooke M, Semple R, Halsall D, Wareham N, Schwabe J, Grasso L, Beck-Peccoz P, Ogunko A, Dattani M, Gurnell M, Chatterjee K.

J Clin Invest. 2010 Dec;120(12):4220-35. doi: 10.1172/JCI43653. Epub 2010 Nov 15.

14.

A liver-derived secretory protein, selenoprotein P, causes insulin resistance.

Misu H, Takamura T, Takayama H, Hayashi H, Matsuzawa-Nagata N, Kurita S, Ishikura K, Ando H, Takeshita Y, Ota T, Sakurai M, Yamashita T, Mizukoshi E, Yamashita T, Honda M, Miyamoto K, Kubota T, Kubota N, Kadowaki T, Kim HJ, Lee IK, Minokoshi Y, Saito Y, Takahashi K, Yamada Y, Takakura N, Kaneko S.

Cell Metab. 2010 Nov 3;12(5):483-95. doi: 10.1016/j.cmet.2010.09.015.

15.

Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation.

Zhang Y, Chen X.

Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E77-85. doi: 10.1152/ajpendo.00380.2010. Epub 2010 Oct 19.

16.

Associations between leptin and the leptin / adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: results from the MONICA / KORA Augsburg study 1984-2002.

Thorand B, Zierer A, Baumert J, Meisinger C, Herder C, Koenig W.

Diabet Med. 2010 Sep;27(9):1004-11. doi: 10.1111/j.1464-5491.2010.03043.x.

PMID:
20722673
17.

High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study.

Zhu N, Pankow JS, Ballantyne CM, Couper D, Hoogeveen RC, Pereira M, Duncan BB, Schmidt MI.

J Clin Endocrinol Metab. 2010 Nov;95(11):5097-104. doi: 10.1210/jc.2010-0716. Epub 2010 Aug 18.

18.

Plasma selenium and risk of dysglycemia in an elderly French population: results from the prospective Epidemiology of Vascular Ageing Study.

Akbaraly TN, Arnaud J, Rayman MP, Hininger-Favier I, Roussel AM, Berr C, Fontbonne A.

Nutr Metab (Lond). 2010 Mar 18;7:21. doi: 10.1186/1743-7075-7-21.

19.

Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial.

Hurst R, Armah CN, Dainty JR, Hart DJ, Teucher B, Goldson AJ, Broadley MR, Motley AK, Fairweather-Tait SJ.

Am J Clin Nutr. 2010 Apr;91(4):923-31. doi: 10.3945/ajcn.2009.28169. Epub 2010 Feb 24.

20.

Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI study.

Stenholm S, Koster A, Alley DE, Visser M, Maggio M, Harris TB, Egan JM, Bandinelli S, Guralnik JM, Ferrucci L.

Clin Endocrinol (Oxf). 2010 Jul;73(1):55-65. doi: 10.1111/j.1365-2265.2009.03742.x.

Supplemental Content

Support Center